The statistical calculations were made with SPSS and then thesignificant parameters were investigated seperately.Results: In ICU, retrospectively, a positive statistical significance was found between polypharmacy and the lenght ofstay with mortality rates in our study with 235 geriatric patients (p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objectives: In this study, we aimed at evaluating the effect of polypharmacy on the mortality and the length of stay ofelderly patients that charged in the ICU.Methods: The patients aged 65 and over which were admitted to the intensive care unit between the dates of September 2018 and August 2019 were included in this study.
📊
Key Findings & Data:Objectives: In this study, we aimed at evaluating the effect of polypharmacy on the mortality and the length of stay ofelderly patients that charged in the ICU.Methods: The patients aged 65 and over which were admitted to the intensive care unit between the dates of September 2018 and August 2019 were included in this study.
💡
Conclusion & Impact:The statistical calculations were made with SPSS and then thesignificant parameters were investigated seperately.Results: In ICU, retrospectively, a positive statistical significance was found between polypharmacy and the lenght ofstay with mortality rates in our study with 235 geriatric patients (p
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters
Abstract
Objectives: In this study, we aimed at evaluating the effect of polypharmacy on the mortality and the length of stay ofelderly patients that charged in the ICU.Methods: The patients aged 65 and over which were admitted to the intensive care unit between the dates of September 2018 and August 2019 were included in this study. The statistical calculations were made with SPSS and then thesignificant parameters were investigated seperately.Results: In ICU, retrospectively, a positive statistical significance was found between polypharmacy and the lenght ofstay with mortality rates in our study with 235 geriatric patients (p
🔖
Cite This Article
DEMİR, İ., BELİCE, T. (2022). Polypharmacy: As a Predictive Indicator of Mortality and Length of Stay for Geriatric Patients Charged in ICU. Eurasian Journal of Medical Investigation, Cilt: 4 - Sayı: 3, 315–319. https://ajindex.com/articles/508692
Nguyen YL, Angus DC, Boumendil A, Guidet B, The challenge of admitting the very elderly to intensive care. Ann Intensive Care 2011;1:29
Fowler RA, Adhikari NK, Bhagwanjee S Clinical review: critical care in the global context—disparities in burden of illness, access, and economics. Crit Care 2008;12:225
US Census Bureau. Population Projections of the United States by Age, Sex, Race, Hispanic Origin and Nativity: 1999–2100. Available Internet access (16.032020): https://www.census. gov/library/working-papers/2002/demo/POP-twps0067.html 4. Chelluri L, Pinsky MR, Donahoe MP, Grenvik A, Long-term outcome of critically ill elderly patients requiring intensive care. JAMA 1993;269:3119–3123
Karaveli A, Cerit G.N, Özyurt E, Evaluation Of Admission Causes And Mortality Rates Of 65 Years Of Age And Older Patients Admitted From The Emergency Department To The Intensive Care Unit Turkish Journal of Geriatrics 2018;21:515–521
Toptas M, Samanci N.S, Akkoc E, Yucetas E, Cebeci E, Sen O, et al. Factors Affecting the Length of Stay in the Intensive Care Unit: Our Clinical Experience, Hindawi BioMed Research International Volume 2018, Article ID 9438046
Wood KA, Ely EW. What does it mean to be critically ill and elderly? Curr Opin Crit Care 2003;9:316–320
De Rooij SE, Govers A, Korevaar JC, Abu-Hanna A, Levi M, de Jonge E, Short-term and long-term mortality in very elderly patients admitted to an intensive care unit. Intensive Care Med 2006;32:1039–1044
Veehof L, Stewart R, Haaijer-Ruskamp F, Jong BM. The development of polypharmacy. A longitudinal study. Fam Pract 2000;17:261–7
United Kingdom Department of Health. Medicines and older people: implementing medicines-related aspects of the The National Service of Framework (NSF) for older people. 2001. Available Internet access (16.032020): https://assets.publishing.service.gov.uk/government/uploads/system/uploads/ attachment_data/file/198033/National_Service_Framework_ for_Older_People.pdf 11. Fillit HM, Futterman R, Orland BI, Chim T, Susnow L, Picariello GP, et al. Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviews. Am J Manag Care 1999;5:587–94
Hajjar ER, Hanlon JT, Sloane RJ, Lindblad CI, Pieper CF, Ruby CM, et al. Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc 2005;53:1518–23
Gamble J-M, Hall JJ, Marrie TJ, Sadowski CA, Majumdar SR, Euric